These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 18167406)

  • 1. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.
    Tanabe KK; Lemoine A; Finkelstein DM; Kawasaki H; Fujii T; Chung RT; Lauwers GY; Kulu Y; Muzikansky A; Kuruppu D; Lanuti M; Goodwin JM; Azoulay D; Fuchs BC
    JAMA; 2008 Jan; 299(1):53-60. PubMed ID: 18167406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.
    Li Y; Xie Q; Lu F; Zhao J; Mao P; Li Z; Liu S; Zhuang H
    Liver Int; 2010 Jan; 30(1):112-8. PubMed ID: 19840254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
    Chen K; Wei Y; Yang H; Li B
    Genet Test Mol Biomarkers; 2011 Apr; 15(4):251-5. PubMed ID: 21186997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
    Baghdadi I; Abu Ella K; El Shaaraway A; Elshayeb E; El-Rebey HS; El Hoseeny M; Naguib M; Nada A
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2047-2053. PubMed ID: 32711431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma.
    Giannitrapani L; Soresi M; Giacalone A; Campagna ME; Marasà M; Cervello M; Marasà S; Montalto G
    OMICS; 2011 Mar; 15(3):183-6. PubMed ID: 21329460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma.
    Abu Dayyeh BK; Yang M; Fuchs BC; Karl DL; Yamada S; Sninsky JJ; O'Brien TR; Dienstag JL; Tanabe KK; Chung RT;
    Gastroenterology; 2011 Jul; 141(1):141-9. PubMed ID: 21440548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
    Charni F; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Trinchet JC; Beaugrand M; Charnaux N; Nahon P
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1439-46. PubMed ID: 21610221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
    Radwan MI; Pasha HF; Mohamed RH; Hussien HI; El-Khshab MN
    Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C.
    Falleti E; Cmet S; Fabris C; Bitetto D; Cussigh A; Fornasiere E; Bignulin E; Feruglio C; Mosanghini E; Fontanini E; Pirisi M; Toniutto P
    Cytokine; 2012 Jan; 57(1):68-73. PubMed ID: 22122913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver disease.
    Falleti E; Fabris C; Toniutto P; Fontanini E; Cussigh A; Bitetto D; Fumolo E; Fornasiere E; Bragagnini W; Pinato DJ; Minisini R; Pirisi M
    Oncology; 2009; 77(5):304-13. PubMed ID: 19940521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease.
    Nischalke HD; Lutz P; Krämer B; Söhne J; Müller T; Rosendahl J; Fischer J; Berg T; Hittatiya K; Fischer HP; Soyka M; Semmo N; Nattermann J; Sauerbruch T; Strassburg CP; Stickel F; Spengler U
    J Hepatol; 2014 Nov; 61(5):1073-9. PubMed ID: 24946282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association of EGF 5'UTR variant A61G and hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.
    Qi P; Wang H; Chen YM; Sun XJ; Liu Y; Gao CF
    Pathology; 2009; 41(6):555-60. PubMed ID: 19900104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of epidermal growth factor in relation to risk of hepatocellular carcinoma: two case-control studies.
    Yuan JM; Fan Y; Ognjanovic S; Wang R; Van Den Berg D; Govindarajan S; Yu MC
    BMC Gastroenterol; 2013 Feb; 13():32. PubMed ID: 23419149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between HLA-G 14-bp insertion/deletion polymorphism and hepatocellular carcinoma in Korean patients with chronic hepatitis B viral infection.
    Kim SK; Chung JH; Jeon JW; Park JJ; Cha JM; Joo KR; Lee JI; Shin HP
    Hepatogastroenterology; 2013 Jun; 60(124):796-8. PubMed ID: 23732778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
    Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
    Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis.
    Machado MV; Janeiro A; Miltenberger-Miltenyi G; Cortez-Pinto H
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):438-43. PubMed ID: 24445728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
    Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
    J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.